84 related articles for article (PubMed ID: 36165234)
1. Prognostic value of
Wang F; Li Y; Li Z; Zou Z; Lu Y; Xu C; Zhao Z; Wang H; Wang Y; Guo S; Jin L; Wang J; Li Q; Jiang G; Xia F; Shen B; Wu J
Future Oncol; 2022 Sep; 18(28):3165-3177. PubMed ID: 36165234
[No Abstract] [Full Text] [Related]
2. GPC5 rs2352028 polymorphism and risk of lung cancer in Han Chinese.
Zheng Y; Kan M; Yu L; Niu X; Zhou D; He L; Lu S; Liu Y
Cancer Invest; 2012 Jan; 30(1):13-9. PubMed ID: 22236185
[TBL] [Abstract][Full Text] [Related]
3. Variants in the 5'-upstream region of GPC5 confer risk of lung cancer in never smokers.
Liu L; Zhong R; Zou L; Fu J; Zhu B; Chen W; Ye X; Gao Y; Yang Y; Christiani DC; Chen S; Miao X
Cancer Epidemiol; 2014 Feb; 38(1):66-72. PubMed ID: 24456789
[TBL] [Abstract][Full Text] [Related]
4. GPC5 rs2352028 variant and risk of lung cancer in never smokers.
Landi MT; Chatterjee N; Caporaso NE; Rotunno M; Albanes D; Thun M; Wheeler W; Rosenberger A; Bickeböller H; Risch A; Wang Y; Gaborieau V; Thorgeirsson T; Gudbjartsson D; Sulem P; Spitz MR; Wichmann HE; Rafnar T; Stefansson K; Houlston RS; Brennan P
Lancet Oncol; 2010 Aug; 11(8):714-6; author reply 716. PubMed ID: 20688270
[No Abstract] [Full Text] [Related]
5. Polymorphisms in C-reactive protein and Glypican-5 are associated with lung cancer risk and Gartrokine-1 influences Cisplatin-based chemotherapy response in a Chinese Han population.
Zhang S; Thakur A; Liang Y; Wang T; Gao L; Yang T; Li Y; Geng T; Jin T; Chen T; Liu JJ; Chen M
Dis Markers; 2015; 2015():824304. PubMed ID: 25999661
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.
Li Y; Sheu CC; Ye Y; de Andrade M; Wang L; Chang SC; Aubry MC; Aakre JA; Allen MS; Chen F; Cunningham JM; Deschamps C; Jiang R; Lin J; Marks RS; Pankratz VS; Su L; Li Y; Sun Z; Tang H; Vasmatzis G; Harris CC; Spitz MR; Jen J; Wang R; Zhang ZF; Christiani DC; Wu X; Yang P
Lancet Oncol; 2010 Apr; 11(4):321-30. PubMed ID: 20304703
[TBL] [Abstract][Full Text] [Related]
7. Significance of
Zou Z; Xu C; Li Z; Yang Y; Li Y; Sun Z; Li Q; Li M; Chen Y; Jiang G; Xiao M; Guo S; Wang Y; Wang H; Xia F; Shang Y; Wu J
Int J Med Sci; 2024; 21(3):474-482. PubMed ID: 38250608
[No Abstract] [Full Text] [Related]
8. GPC5 and lung cancer in multiple sclerosis.
Handel AE; Ramagopalan SV
Lancet Oncol; 2010 Aug; 11(8):714. PubMed ID: 20688271
[No Abstract] [Full Text] [Related]
9. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
[TBL] [Abstract][Full Text] [Related]
10. Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Shin JG; Kim HJ; Park BL; Bae JS; Kim LH; Cheong HS; Shin HD
J Neurol Sci; 2013 Dec; 335(1-2):82-8. PubMed ID: 24135429
[TBL] [Abstract][Full Text] [Related]
11. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
[TBL] [Abstract][Full Text] [Related]
12. Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer.
Yang X; Zhang Z; Qiu M; Hu J; Fan X; Wang J; Xu L; Yin R
Cancer Lett; 2013 Dec; 341(2):265-73. PubMed ID: 23962560
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Interleukin-4 Genotypes to Lung Cancer Risk in Taiwan.
Chang WS; Wang SC; Chuang CL; Ji HX; Hsiao CL; Hsu CM; Tsai CW; Liu SP; Hsu PC; Lo YL; Bau DT
Anticancer Res; 2015 Nov; 35(11):6297-301. PubMed ID: 26504066
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest.
Arking DE; Reinier K; Post W; Jui J; Hilton G; O'Connor A; Prineas RJ; Boerwinkle E; Psaty BM; Tomaselli GF; Rea T; Sotoodehnia N; Siscovick DS; Burke GL; Marban E; Spooner PM; Chakravarti A; Chugh SS
PLoS One; 2010 Mar; 5(3):e9879. PubMed ID: 20360844
[TBL] [Abstract][Full Text] [Related]
15. GPC5, a tumor suppressor, is regulated by miR-620 in lung adenocarcinoma.
Zhao Z; Han C; Liu J; Wang C; Wang Y; Cheng L
Mol Med Rep; 2014 Jun; 9(6):2540-6. PubMed ID: 24682381
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancer.
Xu X; Liu Y; Hu H; Wang J; Cai Y; Xie J; Kang M; He F
World J Surg Oncol; 2023 Aug; 21(1):243. PubMed ID: 37563730
[TBL] [Abstract][Full Text] [Related]
17. Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
Enokida Y; Shimizu K; Atsumi J; Kakegawa S; Takase Y; Kaira K; Yashima H; Araki T; Nakazawa S; Ohtaki Y; Nagashima T; Alexander L; Usui K; Ishikawa T; Hayashizaki Y; Takeyoshi I
Cancer Med; 2016 Aug; 5(8):1791-801. PubMed ID: 27228500
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of GPC5 expression in patients with prostate cancer.
Zhang C; Liu Z; Wang L; Qiao B; Du E; Li L; Xu Y; Zhang Z
Tumour Biol; 2016 May; 37(5):6413-8. PubMed ID: 26631038
[TBL] [Abstract][Full Text] [Related]
19. Associations Between
Zhang H; Chen B; Zou Z; Feng J; Li Y; Wang Y; He X; Xu C; Wang H; Guo S; Jin L; Li Q; Wang J; Xiao M; Li F; Wu J
Front Oncol; 2021; 11():757484. PubMed ID: 34868969
[TBL] [Abstract][Full Text] [Related]
20. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
